Supplemental Figure 3 from AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma
Year: 2023
Type: supplementary-materials
Abstract: Supplemental Figure 3. Genetic ablation of AXL enhances HNSCC cell line response to cisplatin, cetuximab, and radiation
Authors: Toni M. Brand, Mari Iida, Andrew P. Stein, Kelsey L. Corrigan, Cara M. Braverman, John P. Coan, Hannah E. Pearson, Harsh Bahrar, Tyler L. Fowler, Bryan P. Bednarz, Sandeep Saha, David Yang, Parkash S. Gill, Mark W. Lingen, Vassiliki Saloura, Victoria M. Villaflor, Ravi Salgia, Randall J. Kimple, Deric L. Wheeler
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361919015